Since IL-10 has been extensively shown to have an insulin-sensitising effect, it has been found that PTP1B deletion in myeloid cells has a protective role in the development of diabetes by alleviating hepatic and adipose inflammation [65,80]. Here, PTPN1 is linked to diabetes mellitus.